← SynDRA
RAPACURONIUM
SynDRA canonical compound SYN0023553 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | CHRM2 |
|---|
| Mechanism of action | acetylcholine receptor antagonist |
|---|
| Indication | general anaesthetic |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- CHRNA1
- CHRNB1
- CHRND
- CHRNG
- ACHE
- CHRM2
- CHRNE
Mechanisms of action (all sources)
- CHRNA1 ANTAGONIST
- CHRNG ANTAGONIST
- CHRNB1 ANTAGONIST
- CHRND ANTAGONIST
- ACHE ANTAGONIST
- acetylcholine receptor antagonist
- CHRNE ANTAGONIST
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACES
- COMT
- CP2D6
- CP3A4
- GAMT
- GNMT
- HNMT
- NNMT
- PNMT
Drug classes
- Neuromuscular Agents
- Neuromuscular Blocking Agents
- Neuromuscular Nondepolarizing Agents
- Peripheral Nervous System Agents
Cross-references
Synonyms
- RAPLON
- Org 9487
- Org9487
- rapacuronium bromide
- raplon
- Rapacuronium cation
- Rapacuronium ion
- GG1LBM463S
- RefChem:178638
- DTXCID501509816
- UNII-GG1LBM463S
- NCGC00183839-01
- RAPACURONIUM [VANDF]
- SCHEMBL16977930
- CHEBI:135845
- NS00069634
- C37H61N2O4+
- rapacuronii bromidum
- RefChem:57783
- HY-16423
- DTXCID0028749
- EBC-102161
- G12807
- RAPACURONIUM BROMIDE [MART.]
- DA-77347
- UNII-65Q4QDG4KC
- 156137-99-4
- SCHEMBL41132
- RAPACURONIUM BROMIDE [USAN]
- ORG-9487
- Raplon
- RAPACURONIUM BROMIDE [VANDF]
- Rapacuronium bromide
- Tox21_113304
- ORG9487
- MFCD00870871
- RAPACURONIUM BROMIDE [INN]
Look up RAPACURONIUM in the interactive SynDRA portal →